These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3862427)

  • 41. The effect of epostane, a 3-beta hydroxy steroid dehydrogenase inhibitor, on maternal and fetal steroid levels during mid-gestation.
    Selinger M; MacKenzie IZ; Gillmer MD; Phipps SL; Ferguson J
    Br J Obstet Gynaecol; 1988 Jun; 95(6):596-601. PubMed ID: 3291938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects on maternal and fetal steroid concentrations of induction of parturition in the sheep by inhibition of 3 beta-hydroxysteroid dehydrogenase.
    Silver M
    J Reprod Fertil; 1988 Mar; 82(2):457-65. PubMed ID: 2834551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical effects of orally administered extracts of Montanoa tomentosa in early human pregnancy.
    Landgren BM; Aedo AR; Hagenfeldt K; Diczfalusy E
    Am J Obstet Gynecol; 1979 Oct; 135(4):480-4. PubMed ID: 114055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indomethacin increases abortifacient effect of PGE2 in man.
    Piotrowski J; Basta A; Klimczyk K; Małolepazy A; Dłuzniewska M; Spławinski JA
    Prostaglandins; 1979 Mar; 17(3):451-9. PubMed ID: 472338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone.
    Norman JE; Thong KJ; Baird DT
    Lancet; 1991 Nov; 338(8777):1233-6. PubMed ID: 1682644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of an inhibitor of 3 beta-hydroxysteroid dehydrogenase on progesterone concentrations and embryo survival in sheep.
    Ashworth CJ; Wilmut I; Springbett AJ; Webb R
    J Endocrinol; 1987 Feb; 112(2):205-13. PubMed ID: 3469294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of parturition in swine and epostane, a competitive inhibitor of 3 beta-hydroxysteroid dehydrogenase.
    Martin PA; Hammitt DG; Strohbehn RS; Keister DM
    J Anim Sci; 1987 Feb; 64(2):497-506. PubMed ID: 3470276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys.
    Haluska GJ; Cook MJ; Novy MJ
    Am J Obstet Gynecol; 1997 Mar; 176(3):682-91. PubMed ID: 9077629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of prostaglandin E1 analogue pessaries in patients having first trimester induced abortions.
    Nakano R; Hata H; Sasaki K; Yamoto M
    Br J Obstet Gynaecol; 1980 Apr; 87(4):287-91. PubMed ID: 7426498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of inhibiting 3 beta-hydroxysteroid dehydrogenase on plasma progesterone and other steroids in the pregnant mare near term.
    Fowden AL; Silver M
    J Reprod Fertil Suppl; 1987; 35():539-45. PubMed ID: 3479607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relation between plasma oestrogen, progesterone and prolactin concentrations and the efficacy of vaginal prostaglandin E2 gel in initiating labour.
    MacKenzie IZ; Jenkin G; Bradley S
    Br J Obstet Gynaecol; 1979 Mar; 86(3):171-4. PubMed ID: 427057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of 3 beta-hydroxysteroid dehydrogenase in the sow near term: effects on fetal and maternal steroids and on delivery.
    Silver M; Fowden AL
    Q J Exp Physiol; 1988 Jan; 73(1):67-78. PubMed ID: 3162325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy.
    Jain JK; Mishell DR
    N Engl J Med; 1994 Aug; 331(5):290-3. PubMed ID: 8022438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostaglandin-oxytocin enhancement.
    Seppälä M; Vara P
    Br Med J; 1972 Mar; 1(5802):747. PubMed ID: 5015335
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravaginal PGE2 in early abortion.
    Jones JR; Perez RJ
    Prostaglandins; 1974 Jul; 7(2):149-63. PubMed ID: 4852554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological modulation of cervical compliance in the first and second trimesters of pregnancy.
    Calder AA; Greer IA
    Semin Perinatol; 1991 Apr; 15(2):162-72. PubMed ID: 1876872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma progesterone and oestradiol-17beta changes during abortion induced by prostaglandin F2alpha.
    Tyack AJ; Lambadarios C; Parsons RJ; Stewart CR; Cooke ID
    J Obstet Gynaecol Br Commonw; 1974 Jan; 81(1):52-6. PubMed ID: 4818317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester.
    Hill NC; Selinger M; Ferguson J; López Bernal A; Mackenzie IZ
    Br J Obstet Gynaecol; 1990 Jun; 97(6):487-92. PubMed ID: 2198918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulprostone, a synthetic PGE2 analogue in first trimester abortion. Clinical efficacy and influence on serum progesterone of different single doses.
    Larsson B; Jonasson A; Carlström K
    Gynecol Obstet Invest; 1990; 29(1):10-2. PubMed ID: 2351329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.